SightStream Biotherapeutics
Founded 2020
About SightStream Biotherapeutics
SightStream Biotherapeutics develops cytoprotectives to reverse ocular cell death. Its cytoprotectives and pro-regenerative technologies prevent and reverse the death of cells in the ocular cell system, helping healthcare providers aid patients in preventing and recovering from ocular cell damage. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.
Company Facts
- Founded: 2020
- Legal name: SightStream Biotherapeutics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Website: sightstreambio.com
- Phone: 617-388-2635
Social Profiles
Canonical: https://fsome.com/organization/sightstream-biotherapeutics-8363010 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.